Define and drive the toxicology testing strategy across preclinical and clinical programs, ensuring alignment with overall portfolio goals.
Serve as a PreClinical Science thought leader, integrating existing and emerging toxicological approaches into program strategy and clinical development plans in support of program advancement and key regulatory milestones.
Represent toxicology in cross-functional governance and portfolio planning forums.
Partner with other functions (Translational Biomarkers, Research, and clinical teams) to guide evaluation of targets and programs to contextualize nonclinical safety findings.
Functional & Scientific Oversight
Operational excellence of Toxicology Function: Includes the fostering of collaborative CRO interactions to deliver timely and high-quality toxicology data, maintenance of timelines, costs, and risk assessment/management.
Leverage existing and emerging NAMs to support the advancement of monoclonal antibodies across the research and development portfolio.
Lead the design and execution of toxicology studies, working cross-functionally to incorporate bioanalytical and translational biomarkers to address nonclinical safety questions.
Author and review toxicology sections of INDs, CTAs, IBs, CSRs, and other regulatory filings.
Collaborate with Clinical Development to understand the potential relevance of nonclinical safety signals.
Distill large nonclinical safety datasets for key messaging; interpret and communicate findings to key stakeholders within Research and Development.
Contribute to the evaluation of novel modalities and combination strategies to support advancement of Scholar Rock’s portfolio.
Candidate Requirements:
PhD in biology, toxicology, pharmacology, veterinary medicine, or related discipline; DABT Certification strongly preferred.
10+ years of toxicology experience within biotech/pharma; proficiency in the development of monoclonal antibodies preferred.
Familiar with GLP requirements and ICH guidelines.
Experience in the design, conduct, and interpretation of nonclinical safety studies and the management of external CROs.
Strong analytical and communication skills; ability to distill complex data into key messages for stakeholders and regulatory submissions.
Proficient in scientific documentation supporting submissions to regulatory agencies.
Passion for rare disease research and a commitment to improving patients’ lives.